SCHEMBL26696756

SCHEMBL26696756

O=[N+]([O-])c1cccc(CNc2cc(Cl)nc3c(C4CC4)cnn23)c1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KCNN3 Q9UGI6 5/20 0.64
▸ POLB P06746 1/20 0.43
▸ JAK2 O60674 2/20 0.42
▸ JAK3 P52333 2/20 0.42
▸ PTK2 Q05397 2/20 0.42
▸ GSK3B P49841 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ KCNN1 Q92952 1/20 0.40
▸ KCNN2 Q9H2S1 1/20 0.40
▸ MET P08581 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HRH4 Q9H3N8 1/20 0.40
▸ PDE5A O76074 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22413208 0.86 KCNN3 (0.58) KCNN3GSK3BMEN1KMT2AKCNN1
SCHEMBL22413144 0.84 KCNN3 (0.48) KCNN3GSK3BKCNN1KCNN2
SCHEMBL18051111 0.83 KCNN3 (0.64) KCNN3MAPK1MAPTMEN1KMT2A
SCHEMBL30872083 0.79 KCNN3 (0.49) KCNN3GSK3BMEN1KMT2AKCNN1
SCHEMBL12954018 0.78 CDK2 (0.52) KCNN3GSK3BMEN1KMT2AKCNN1
SCHEMBL30083511 0.77 KCNN3 (0.42) KCNN3GSK3BMEN1KMT2AKCNN1
SCHEMBL26697079 0.77 KCNN3 (0.42) KCNN3POLBMAPK1MAPTMEN1
SCHEMBL30083523 0.77 KCNN3 (0.44) KCNN3GSK3BMAPTMEN1KMT2A
SCHEMBL30083401 0.75 GSK3B (0.45) KCNN3GSK3BMEN1KMT2AKCNN1
SCHEMBL30083536 0.75 BRD4 (0.49) KCNN3GSK3BKCNN1KCNN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023227125-A1 NEW FUSED-HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOF 杭州德睿智药科技有限公司 2023-11-30 — — WO disclosed
Send feedback